Feb 23, 2011 | Digital Pathology, Laboratory News, Laboratory Pathology
Goal is to produce accurate sequence of one human cancer cell; could lead to new cancer tests Pathologists and clinical laboratory managers will find the latest “prize” for a genetic breakthrough to have direct relevance to molecular diagnostics. One million dollars will go to the first person who sequences an entire cancer cell genome, including all of the RNA, using a specific whole human genome sequencer made by Carlsbad, California-based Life Technologies (NASDAQ: LIFE). This is the fourth...